{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:09Z","timestamp":1793158149601,"version":"4.5.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004728","name":"Vellore Institute of Technology Deemed to be University","doi-asserted-by":"publisher","award":["SG20250047"],"award-info":[{"award-number":["SG20250047"]}],"id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cellsig.2026.112726","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:20:05Z","timestamp":1783437605000},"page":"112726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Gut microbiome-mediated modulation of the glioblastoma tumor microenvironment for enhanced immunotherapy response: Mechanistic insights and future perspectives"],"prefix":"10.1016","volume":"147","author":[{"given":"Urjaswee","family":"Dey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Priya","family":"Madabhushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amisha Anna","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilash Valsala","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameshkumar","family":"Santhanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Gajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112726_bb0005","series-title":"StatPearls [Internet]","article-title":"Glioblastoma Multiforme","author":"Kanderi","year":"2024"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17010146","article-title":"Glioblastoma: clinical presentation, multidisciplinary management, and long-term outcomes","volume":"17","author":"Sipos","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-13320-4","article-title":"Survival prediction of glioblastoma patients using machine learning and deep learning: a systematic review","volume":"24","author":"Poursaeed","year":"2024","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112726_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102412","article-title":"Epidemiology of glioblastoma multiforme\u2013literature review","volume":"14","author":"Grochans","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cellsig.2026.112726_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2025.102811","article-title":"Adult glioblastoma in England: incidence, treatment, and outcomes with novel population-based strata","volume":"97","author":"Le Calvez","year":"2025","journal-title":"Cancer Epidemiol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112726_bb0030","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/neuonc\/noz123","article-title":"Risk factors for childhood and adult primary brain tumors","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro-oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112726_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.32074\/1591-951X-823","article-title":"Adult type diffuse gliomas in the new 2021 WHO classification","volume":"114","author":"Antonelli","year":"2022","journal-title":"Pathologica"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112726_bb0040","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00701-022-05301-y","article-title":"The WHO 2021 classification of central nervous system tumours: a practical update on what neurosurgeons need to know\u2014a minireview","volume":"164","author":"Torp","year":"2022","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.cellsig.2026.112726_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.900377","article-title":"The routine application of tumor-treating fields in the treatment of glioblastoma WHO IV","volume":"13","author":"Krigers","year":"2022","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0050","first-page":"426","article-title":"Tumor-treating fields for the treatment of glioblastoma: a systematic review and meta-analysis","volume":"8","author":"Regev","year":"2021","journal-title":"Neurol. Pract."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41467-025-66747-z","article-title":"Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib\/II GEINO 1602 trial","volume":"17","author":"Vaz-Salgado","year":"2025","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112726_bb0060","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cellsig.2026.112726_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.603947","article-title":"Effectiveness of lomustine combined with bevacizumab in glioblastoma: a meta-analysis","volume":"11","author":"Ren","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0070","first-page":"1","article-title":"Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience","author":"Cerretti","year":"2025","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0075","article-title":"Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance","volume":"16","author":"Pu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.786700","article-title":"Nanotherapeutics overcoming the blood-brain barrier for glioblastoma treatment","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00457-24","article-title":"Multi-omics analysis reveals the interplay between intratumoral bacteria and glioma","volume":"10","author":"Li","year":"2025","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s43046-025-00317-8","article-title":"Role of tumor microenvironment in cancer promotion, development of drug resistance and cancer treatment","volume":"37","author":"Fathah","year":"2025","journal-title":"J. Egypt. Natl. Canc. Inst."},{"key":"10.1016\/j.cellsig.2026.112726_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1308263","article-title":"Association between gut microbiota and glioblastoma: a Mendelian randomization study","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0105","article-title":"Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112726_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102965","article-title":"Current advances in PD-1\/PD-L1 axis-related tumour-infiltrating immune cells and therapeutic regimens in glioblastoma","volume":"151","author":"Shu","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"33","key":"10.1016\/j.cellsig.2026.112726_bb0115","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.2217\/fon-2021-0435","article-title":"Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China","volume":"17","author":"Wang","year":"2021","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02228-7","article-title":"Bidirectional role of neutrophils in tumor development","volume":"24","author":"Luyang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.20892\/j.issn.2095-3941.2019.0353","article-title":"Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1\/RAGE\/IL-8 axis","volume":"17","author":"Zha","year":"2020","journal-title":"Cancer Biol. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11041069","article-title":"Challenges and opportunities for immunotherapeutic intervention against myeloid immunosuppression in glioblastoma","volume":"11","author":"Exley","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0135","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2024.00212","article-title":"Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment","volume":"5","author":"Jou","year":"2024","journal-title":"Explor. Target. Anti-tumor Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112726_bb0140","doi-asserted-by":"crossref","DOI":"10.15698\/cst2019.02.176","article-title":"Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma","volume":"3","author":"Won","year":"2019","journal-title":"Cell Stress"},{"key":"10.1016\/j.cellsig.2026.112726_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.603495","article-title":"The role of microglia in glioblastoma","volume":"10","author":"Geribaldi-Dold\u00e1n","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00506","article-title":"Harnessing microglia and macrophages for the treatment of glioblastoma","volume":"10","author":"Prionisti","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0155","series-title":"Molecular Mechanisms of Glioma Cell Motility","first-page":"73","author":"Armento","year":"2017"},{"key":"10.1016\/j.cellsig.2026.112726_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/cells10010018","article-title":"Myeloid cells in glioblastoma microenvironment","volume":"10","author":"De Leo","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112726_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13092172","article-title":"The gut-brain axis in brain tumors: insights into tumor development, progression, and therapy","volume":"13","author":"Scuderi","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-026-01680-3","article-title":"The gut-brain-immune axis in glioma: emerging mechanisms and therapeutic opportunities","volume":"46","author":"Feng","year":"2026","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0175","article-title":"Single-cell image analysis reveals a protective role for microglia in glioblastoma","volume":"3","author":"Woolf","year":"2021","journal-title":"Neuro-oncol. Adv."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01670-1","article-title":"Targeting the tumor stroma for cancer therapy","volume":"21","author":"Xu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04575-9","article-title":"Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1 (eng)","key":"10.1016\/j.cellsig.2026.112726_bb0190","first-page":"70","article-title":"Migration of regulatory T cells to the peritumor microenvironment of experimental glioblastoma","volume":"17","author":"Yanysheva","year":"2025","journal-title":"\u0421\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u044b\u0435 \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0438 \u0432 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0435"},{"key":"10.1016\/j.cellsig.2026.112726_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.693215","article-title":"Metabolic remodeling in glioma immune microenvironment: intercellular interactions distinct from peripheral tumors","volume":"9","author":"Qiu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112726_bb0200","article-title":"4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy","volume":"6","author":"Cha","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112726_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225698","article-title":"Inhibition of the adenosinergic pathway in cancer rejuvenates innate and adaptive immunity","volume":"20","author":"Azambuja","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112726_bb0210","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coph.2020.07.001","article-title":"Targeting CD73 to augment cancer immunotherapy","volume":"53","author":"Roh","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0215","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1007\/s11033-021-07069-3","article-title":"The significance of the SDF-1\/CXCR4 signaling pathway in the normal development","volume":"49","author":"Sadri","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112726_bb0220","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-024-05714-5","article-title":"Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors","volume":"150","author":"Kang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112726_bb0235","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood\u2013brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112726_bb0240","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112726_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26072935","article-title":"The role of gut microbiome on glioblastoma oncogenesis and malignant evolution","volume":"26","author":"Mohamed","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112726_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12061068","article-title":"Gut microbiota and antibiotic treatments for the main non-oncologic hepato-biliary-pancreatic disorders","volume":"12","author":"Di Vincenzo","year":"2023","journal-title":"Antibiotics"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112726_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17111849","article-title":"Immunotherapy for high-grade gliomas","volume":"17","author":"Karbhari","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/noac099","article-title":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial","volume":"25","author":"Omuro","year":"2023","journal-title":"Neuro-Oncology"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112726_bb0270","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112726_bb0275","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"issue":"399","key":"10.1016\/j.cellsig.2026.112726_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O\u2019Rourke","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0285","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112726_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17152550","article-title":"Oncolytic therapies for glioblastoma: advances, challenges, and future perspectives","volume":"17","author":"Alomari","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.cellsig.2026.112726_bb0295","first-page":"452","article-title":"Survival prediction using apparent diffusion coefficient values in recurrent glioblastoma under bevacizumab treatment","volume":"30","author":"Liu","year":"2024","journal-title":"Diagn. Interv. Radiol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112726_bb0300","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112726_bb0305","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","article-title":"Targeting tumor-associated macrophages for cancer treatment","volume":"12","author":"Li","year":"2022","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0315","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01156-z","article-title":"Macrophages and microglia: the cerberus of glioblastoma","volume":"9","author":"Buonfiglioli","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112726_bb0320","article-title":"The effect of plerixafor on the migration of immune stem cells into the tumor site and survival of rats with C6 glioma (experimental study)","volume":"16","author":"Pak","year":"2024","journal-title":"Russian Neurosurg. J."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112726_bb0325","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1021\/acscentsci.9b01235","article-title":"M2-like tumor-associated macrophage-targeted codelivery of STAT6 inhibitor and IKK\u03b2 siRNA induces M2-to-M1 repolarization for cancer immunotherapy with low immune side effects","volume":"6","author":"Xiao","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112726_bb0330","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.3390\/cimb46080462","article-title":"Phagocytosis checkpoints in glioblastoma: CD47 and beyond","volume":"46","author":"Afzal","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-023-00549-7","article-title":"Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities","volume":"12","author":"Qian","year":"2024","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0340","article-title":"Single-cell sequencing to multi-omics: technologies and applications","volume":"12","author":"Yang","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cellsig.2026.112726_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.915218","article-title":"Gut microflora modulates Th17\/Treg cell differentiation in experimental autoimmune prostatitis via the short-chain fatty acid propionate","volume":"13","author":"Du","year":"2022","journal-title":"Front. Immunol."},{"issue":"90","key":"10.1016\/j.cellsig.2026.112726_bb0350","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo5558","article-title":"Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion","volume":"8","author":"Whiteside","year":"2023","journal-title":"Sci. Immunol."},{"issue":"30","key":"10.1016\/j.cellsig.2026.112726_bb0995","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0990","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0355","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s40001-024-01711-z","article-title":"The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review","volume":"29","author":"Abdul-Rahman","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0505","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short-chain fatty acids","volume":"5","author":"Corr\u00eaa-Oliveira","year":"2016","journal-title":"Clin. Transl. Immunol."},{"issue":"76","key":"10.1016\/j.cellsig.2026.112726_bb0985","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abk0957","article-title":"BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors","volume":"7","author":"Itahashi","year":"2022","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0360","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","article-title":"Blood\u2013brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy","volume":"10","author":"Galstyan","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0365","article-title":"Glioma and the gut\u2013brain axis: opportunities and future perspectives","volume":"4","author":"Nickles","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.cellsig.2026.112726_bb0370","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cns.14081","article-title":"Gut microbiota in brain tumors: an emerging crucial player","volume":"29","author":"Lin","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112726_bb0375","doi-asserted-by":"crossref","first-page":"13477","DOI":"10.1007\/s00432-023-05199-8","article-title":"Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy","volume":"149","author":"Fan","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0385","article-title":"Gut microbiome alterations affect glioma development and Foxp3 expression in tumor microenvironment in mice","volume":"12","author":"Fan","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112726_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0324742","article-title":"Gut microbiota and its influence on the gut-brain axis in comparison with chemotherapy patients and cancer-free control data in breast cancer\u2014a computational perspective","volume":"20","author":"Loganathan","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2026.112726_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103493","article-title":"Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells","volume":"105","author":"Wenzel","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0935","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1039\/D2FO01683D","article-title":"Therapeutic potential and nutritional significance of Ganoderma lucidum\u2013a comprehensive review from 2010 to 2022","volume":"14","author":"Swallah","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.cellsig.2026.112726_bb0425","article-title":"Association between oral microbiota and human brain glioma grade: a case-control study","volume":"11","author":"Wen","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112726_bb0435","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171311","article-title":"Meta-analysis of oral microbiomes reveals sex-based diversity in biofilms during periodontitis","volume":"9","author":"Del Pinto","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.cellsig.2026.112726_bb0615","doi-asserted-by":"crossref","DOI":"10.1002\/alz.083658","article-title":"How gut bacteria influence the brain barriers, neuroinflammation and Alzheimer\u2019s disease: a role for bacterial metabolites and extracellular vesicles","volume":"20","author":"Vandenbroucke","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112726_bb0840","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.1021\/acsnano.4c13599","article-title":"Extracellular vesicles carrying tenascin-C are clinical biomarkers and improve tumor-derived DNA analysis in glioblastoma patients","volume":"19","author":"Salviano-Silva","year":"2025","journal-title":"ACS Nano"},{"issue":"48","key":"10.1016\/j.cellsig.2026.112726_bb0380","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.3748\/wjg.v30.i48.5104","article-title":"Bidirectional relationship between gastrointestinal cancer and depression: the key is in the microbiota\u2013gut\u2013brain axis","volume":"30","author":"Priego-Parra","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1542142","article-title":"The microbial landscape of tumors: a deep dive into intratumoral microbiota","volume":"16","author":"Asgharzadeh","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0400","article-title":"Combination of sodium butyrate and immunotherapy in glioma: regulation of immunologically hot and cold tumors via gut microbiota and metabolites","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112726_bb0405","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1111\/cas.15901","article-title":"Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis","volume":"114","author":"Hayashi","year":"2023","journal-title":"Cancer Sci."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112726_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215317","article-title":"Gut microbiota and tumor immune escape: a new perspective for improving tumor immunotherapy","volume":"14","author":"He","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cellsig.2026.112726_bb0415","article-title":"Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112726_bb0865","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/jpm13060999","article-title":"MGMT promoter methylation: prognostication beyond treatment response","volume":"13","author":"Ashkan","year":"2023","journal-title":"J. Pers. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.cellsig.2026.112726_bb0765","doi-asserted-by":"crossref","first-page":"v13","DOI":"10.1093\/neuonc\/noad179.0051","article-title":"BIOM-40. Therabiome-gbm: therapeutic outcomes related to gut microbiome in glioblastoma (GBM) patients receiving chemo-radiation: a prospective observational study","volume":"25","author":"Ng","year":"2023","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0815","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.cellsig.2026.112726_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117207","article-title":"The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: a systematic review","volume":"178","author":"Lu","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0800","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/abt\/tbad021","article-title":"Development of a human glioblastoma model using humanized DRAG mice for immunotherapy","volume":"6","author":"Srivastava","year":"2023","journal-title":"Antibody Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0805","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-019-0767-6","article-title":"Advancing functional and translational microbiome research using meta-omics approaches","volume":"7","author":"Zhang","year":"2019","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0810","article-title":"Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma","volume":"3","author":"Dees","year":"2021","journal-title":"Neuro-oncol. Adv."},{"key":"10.1016\/j.cellsig.2026.112726_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1685862","article-title":"Emerging technologies and current challenges in intratumoral microbiota research","volume":"15","author":"Wang","year":"2026","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1164654","article-title":"Bacteria associated with glioma: a next wave in cancer treatment","volume":"13","author":"Meng","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112726_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37284","article-title":"Gender-specific microbial signatures in saliva: unveiling the association between the oral microbiome and the pathogenesis of glioma","volume":"10","author":"Qin","year":"2024","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112726_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071228","article-title":"Exploring the microbiome\u2019s impact on glioma and brain metastases: insights into development, progression, and treatment response\u2014a scoping review","volume":"17","author":"Leigh","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0450","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-01983-x","article-title":"Gut microbiota-mediated immunomodulation in tumor","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112726_bb0455","first-page":"1","article-title":"The gut microbiota in cancer immunity and immunotherapy","author":"Xie","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112726_bb0460","doi-asserted-by":"crossref","first-page":"115825","DOI":"10.1016\/j.celrep.2025.115825","article-title":"Gut microbiota dysbiosis induced by brain tumors modulates the efficacy of immunotherapy","volume":"44","author":"Kim","year":"2025","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112726_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111039","article-title":"Gut Lactobacillus contributes to the progression of breast cancer by affecting the anti-tumor activities of immune cells in the TME of tumor-bearing mice","volume":"124","author":"Shi","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112726_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105740","article-title":"Short-chain fatty acids augment differentiation and function of human induced regulatory T cells","volume":"23","author":"Hu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0480","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2026.2623349","article-title":"Muribaculum intestinale negatively impacts glioma growth in mice through the toll-like receptor 2","volume":"18","author":"Marrocco","year":"2026","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0490","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1038\/s41598-022-27086-x","article-title":"Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids","volume":"13","author":"Caetano-Silva","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2026.112726_bb0495","doi-asserted-by":"crossref","unstructured":"Zhou, F., Wang, X., Han, B., Tang, X., Liu, R., Ji, Q., \u2026 & Zhang, L. (2021). Short-chain fatty acids contribute to neuropathic pain via regulating microglia activation and polarization. Mol. Pain, 17, 1744806921996520.","DOI":"10.1177\/1744806921996520"},{"key":"10.1016\/j.cellsig.2026.112726_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113062","article-title":"Indoleamine 2, 3-dioxygenase-1 involves in CD8+ T cell exhaustion in glioblastoma via regulating tryptophan levels","volume":"142","author":"Zhou","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0510","article-title":"Glioma-05 a novel concept for treatment of glioblastoma: vagus nerve electrical stimulation for suppression of cytokine (IL-6) signaling","volume":"5","author":"Brem","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0515","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41392-025-02226-7","article-title":"Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment","volume":"10","author":"Cao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112726_bb0520","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3892\/ijmm.2024.5426","article-title":"Lipid metabolic rewiring in glioma-associated microglia\/macrophages","volume":"54","author":"Ma","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellsig.2026.112726_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1573039","article-title":"Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0530","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/19768354.2024.2336249","article-title":"Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment","volume":"28","author":"Kim","year":"2024","journal-title":"Anim. Cells Syst."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0710","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2569739","article-title":"Gut microbiome metagenomics in clinical practice: bridging the gap between research and precision medicine","volume":"17","author":"Tegegne","year":"2025","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0535","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR\u2013S6K pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0540","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cei\/uxab028","article-title":"The effect of SCFAs on M2 macrophage polarization in MH-S cells","volume":"207","author":"Huang","year":"2022","journal-title":"Clin. Exp. Immunol."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112726_bb0545","article-title":"PERK-mediated cholesterol excretion from IDH mutant glioma determines anti-tumoral polarization of microglia","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0550","article-title":"Fatty acids in cancer: metabolic functions and potential treatment","volume":"2","author":"Du","year":"2023","journal-title":"MedComm Oncol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040657","article-title":"Mechanisms of blood\u2013brain barrier protection by microbiota-derived short-chain fatty acids","volume":"12","author":"Fock","year":"2023","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112726_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083532","article-title":"Breaking the barrier: the role of proinflammatory cytokines in BBB dysfunction","volume":"26","author":"Gryka-Marton","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112726_bb0565","article-title":"Gut microbiota regulates blood-cerebrospinal fluid barrier function mainly by modulating subcellular localization of tight junction proteins","volume":"42","author":"Xie","year":"2023","journal-title":"EMBO J."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112726_bb0570","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111515","article-title":"Gut microbiota regulates blood-cerebrospinal fluid barrier function and a\u03b2 pathology","volume":"42","author":"Xie","year":"2023","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112726_bb0575","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cellsig.2026.112726_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662807","article-title":"Exploring the gut-brain axis for the control of CNS inflammatory demyelination: immunomodulation by Bacteroides fragilis\u2019 polysaccharide A","volume":"12","author":"Erturk-Hasdemir","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0585","article-title":"The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1291724","article-title":"The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease","volume":"14","author":"Prame Kumar","year":"2023","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0595","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112726_bb0600","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","article-title":"Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health","volume":"11","author":"Parker","year":"2020","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0605","article-title":"Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112726_bb0610","article-title":"The microbial landscape of tumors: a deep dive into intratumoral microbiota and its role in cancer biology","volume":"16","author":"Tao","year":"2025","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112726_bb0620","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/neuonc\/nox210","article-title":"Monoamines in glioblastoma: complex biology with therapeutic potential","volume":"20","author":"Caragher","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.cellsig.2026.112726_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104061","article-title":"Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet","volume":"80","author":"Dahlin","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellsig.2026.112726_bb0635","article-title":"Gut microbiota's role in glioblastoma risk, with a focus on the mediating role of metabolites","volume":"15","author":"Li","year":"2024","journal-title":"Front. Neurol."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112726_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/nu17172898","article-title":"The microbiota\u2013diet\u2013immunity axis in cancer care: from prevention to treatment modulation and survivorship","volume":"17","author":"Tini","year":"2025","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0645","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1109\/TMBMC.2025.3585798","article-title":"Modeling and analysis of SCFA-driven Vagus nerve signaling in the gut-brain axis via molecular communication","volume":"11","author":"Ortlek","year":"2025","journal-title":"IEEE Trans. Mol. Biol. Multi-Scale Commun."},{"key":"10.1016\/j.cellsig.2026.112726_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1588850","article-title":"New intervention strategy for postoperative fatigue syndrome in elderly patients with colorectal cancer: a clinical hypothesis study based on vagus nerve stimulation","volume":"12","author":"Yin","year":"2025","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112726_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/biom15030404","article-title":"Pathological and inflammatory consequences of aging","volume":"15","author":"Garc\u00eda-Dom\u00ednguez","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.cellsig.2026.112726_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772555","article-title":"Transcutaneous vagal nerve stimulation alone or in combination with radiotherapy stimulates lung tumor infiltrating lymphocytes but fails to suppress tumor growth","volume":"12","author":"Reijmen","year":"2021","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112726_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911495","article-title":"Gut\u2013brain axis: insights from hippocampal neurogenesis and brain tumor development in a mouse model of experimental colitis induced by dextran sodium sulfate","volume":"23","author":"Vitali","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112726_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225577","article-title":"Interactions between dietary micronutrients, composition of the microbiome and efficacy of immunotherapy in cancer patients","volume":"14","author":"Fr\u0105k","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0675","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40164-023-00442-x","article-title":"Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target","volume":"12","author":"Zhang","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0680","series-title":"Intervention with Muscadine Grape Extract and Probiotics Modulates Western Diet-Associated Triple-Negative Breast Tumor Growth and Improves Prognosis in Murine Models","author":"Newman","year":"2023"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0685","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01212-7","article-title":"Adherence to plant-based dietary patterns in relation to glioma: a case\u2013control study","volume":"11","author":"Mousavi","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112726_bb0690","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.ccell.2025.09.002","article-title":"Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate production","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2026.112726_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.770796","article-title":"Long term survivals in aggressive primary brain malignancies treated with an adjuvant ketogenic diet","volume":"9","author":"Schwartz","year":"2022","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0700","article-title":"Intermittent fasting inhibits Tp53-driven glioma through gut microbiota-mediated methionine-m6A regulation","volume":"17","author":"Lin","year":"2026","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112726_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235912","article-title":"Targeting metabolism to control immune responses in cancer and improve checkpoint blockade immunotherapy","volume":"13","author":"Luby","year":"2021","journal-title":"Cancers"},{"issue":"6371","key":"10.1016\/j.cellsig.2026.112726_bb0715","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0720","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-018-2394-3","article-title":"Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series","volume":"18","author":"Costa","year":"2018","journal-title":"BMC Complement. Altern. Med."},{"issue":"6529","key":"10.1016\/j.cellsig.2026.112726_bb0725","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.cellsig.2026.112726_bb0730","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2026.112726_bb0735","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ebiom.2019.03.070","article-title":"Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients","volume":"44","author":"Wardill","year":"2019","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112726_bb0740","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/17425247.2023.2241367","article-title":"Synthetic engineered bacteria for cancer therapy","volume":"20","author":"Gong","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"issue":"530","key":"10.1016\/j.cellsig.2026.112726_bb0745","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112726_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112881","article-title":"Short-chain fatty acids reverses gut microbiota dysbiosis-promoted progression of glioblastoma by up-regulating M1 polarization in the tumor microenvironment","volume":"141","author":"Zhou","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0755","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2147\/DDDT.S298261","article-title":"Temozolomide-induced changes in gut microbial composition in a mouse model of brain glioma","author":"Li","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0760","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04042-5","article-title":"Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma","volume":"21","author":"Hou","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0875","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40168-018-0483-7","article-title":"Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies","volume":"6","author":"Panebianco","year":"2018","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0770","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-med-042320-014032","article-title":"The gut\u2013brain axis","volume":"73","author":"Mayer","year":"2022","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0775","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0780","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-025-03434-2","article-title":"Gut microbiota and their influence in brain cancer milieu","volume":"22","author":"BharathwajChetty","year":"2025","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0785","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-024-02224-5","article-title":"Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease","volume":"29","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0790","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13046-021-01845-6","article-title":"Gut microbiota influence tumor development and alter interactions with the human immune system","volume":"40","author":"Ge","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0795","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1479-5876-12-107","article-title":"Immunocompetent murine models for the study of glioblastoma immunotherapy","volume":"12","author":"Oh","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112726_bb0820","series-title":"THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-Radiation (THERABIOME-GBM)","author":"Ottawa Hospital Research Institute","year":"2023"},{"key":"10.1016\/j.cellsig.2026.112726_bb0825","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.2147\/IJN.S374024","article-title":"Selenium nanoparticles-enriched Lactobacillus casei ATCC 393 prevents cognitive dysfunction in mice through modulating microbiota-gut-brain axis","author":"Qiao","year":"2022","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112726_bb0830","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41416-019-0603-6","article-title":"Circulating biomarkers in patients with glioblastoma","volume":"122","author":"M\u00fcller Bark","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"Supplement_2","key":"10.1016\/j.cellsig.2026.112726_bb0835","doi-asserted-by":"crossref","first-page":"ii45","DOI":"10.1093\/noajnl\/vdac015","article-title":"Circulating tumor cells and extracellular vesicles as liquid biopsy markers in neuro-oncology: prospects and limitations","volume":"4","author":"Westphal","year":"2022","journal-title":"Neuro-oncol. Adv."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112726_bb0845","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20178124","article-title":"Multi-omics factor analysis\u2014a framework for unsupervised integration of multi-omics data sets","volume":"14","author":"Argelaguet","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0850","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.csbj.2021.06.030","article-title":"Integration strategies of multi-omics data for machine learning analysis","volume":"19","author":"Picard","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112726_bb0855","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41592-021-01198-0","article-title":"Spacem reveals metabolic states of single cells","volume":"18","author":"Rappez","year":"2021","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0860","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-023-01494-6","article-title":"Advances in single-cell RNA sequencing and its applications in cancer research","volume":"16","author":"Huang","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0870","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s40168-022-01373-1","article-title":"Reproducible and opposing gut microbiome signatures distinguish autoimmune diseases and cancers: a systematic review and meta-analysis","volume":"10","author":"Islam","year":"2022","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0880","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/acs.chemrev.2c00431","article-title":"Microbiome and human health: current understanding, engineering, and enabling technologies","volume":"123","author":"Aggarwal","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cellsig.2026.112726_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1166104","article-title":"Personalised therapeutic approaches to glioblastoma: a systematic review","volume":"10","author":"Mowforth","year":"2023","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0890","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40168-023-01737-1","article-title":"Gut microbiome-metabolome interactions predict host condition","volume":"12","author":"Shtossel","year":"2024","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0895","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13059-024-03343-2","article-title":"Genomic reproducibility in the bioinformatics era","volume":"25","author":"Baykal","year":"2024","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0900","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12672-025-04088-5","article-title":"Omics-enhanced nanomedicine: integrating multi-omics for precision cancer diagnosis and therapy","volume":"17","author":"Yan","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0905","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-biodatasci-102523-103801","article-title":"Harnessing artificial intelligence in multimodal omics data integration: paving the path for the next frontier in precision medicine","volume":"7","author":"Nam","year":"2024","journal-title":"Annu. Rev. Biomed. Data Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0910","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-017-0691-z","article-title":"Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria","volume":"16","author":"LeBlanc","year":"2017","journal-title":"Microb. Cell Factories"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0915","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-023-09885-2","article-title":"Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study","volume":"24","author":"Zeng","year":"2023","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0920","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01610-7","article-title":"Overcoming the blood\u2013brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches","volume":"20","author":"Mitusova","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112726_bb0925","article-title":"WNT2 blockade augments antitumor immunity by attenuating myeloid-derived suppressor cells in colorectal cancer","volume":"3","author":"Cui","year":"2024","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0930","first-page":"10","article-title":"Multi-omics technologies: novel tools and methods for assessing nerve injury and regeneration","author":"Zhou","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112726_bb0940","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"23","key":"10.1016\/j.cellsig.2026.112726_bb0945","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311290","article-title":"Specific intratumoral microbiome signatures in human glioblastoma and meningioma: evidence for a gut\u2013brain microbial axis","volume":"26","author":"Mehelleb","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112726_bb0950","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2186671","article-title":"Microbiota-directed biotherapeutics: considerations for quality and functional assessment","volume":"15","author":"Fekete","year":"2023","journal-title":"Gut Microbes"},{"issue":"25","key":"10.1016\/j.cellsig.2026.112726_bb0955","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017947118","article-title":"The human gut microbiome and health inequities","volume":"118","author":"Amato","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2026.112726_bb0960","doi-asserted-by":"crossref","DOI":"10.1002\/imm3.70030","article-title":"Targeting microbiome metabolites: reshaping immunotherapy and clinical management strategies for colorectal cancer","volume":"2","author":"Yang","year":"2026","journal-title":"iMetaMed"},{"key":"10.1016\/j.cellsig.2026.112726_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117031","article-title":"The gut microbiota derived metabolite trimethylamine N-oxide: its important role in cancer and other diseases","volume":"177","author":"Zhou","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112726_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106707","article-title":"RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma","volume":"87","author":"Jin","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112726_bb0975","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14847","article-title":"GV-971 attenuates the progression of neuromyelitis optica in murine models and reverses alterations in gut microbiota and associated peripheral abnormalities","volume":"30","author":"Yang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112726_bb0980","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/acs.molpharmaceut.4c00950","article-title":"Macrophage membrane-coated nanomedicine enhances cancer immunotherapy by activating macrophages and T cells","volume":"22","author":"Zhao","year":"2025","journal-title":"Mol. Pharm."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:43:36Z","timestamp":1787053416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":199,"alternative-id":["S0898656826003827"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112726","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome-mediated modulation of the glioblastoma tumor microenvironment for enhanced immunotherapy response: Mechanistic insights and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112726"}}